|
Medical conditions
Systemic hypertension
Migraine or vascular headaches.
Asthma or chronic obstructive pulmonary
disease with bronchospasm.
Hyperthyroidism.
Raynaud's syndrome.
Insulin-dependent diabetes mellitus
Non-insulin-dependent diabetes mellitus.
Depression.
Mild peripheral vascular disease
Severe peripheral vascular disease with rest ischemia.
Cardiac arrhythmias and conduction abnormalities.
Sinus bradycardia.
Sinus tachycardia (not due to heart
failure).
Supraventncular tachycardia.
Atrioventricular block.
Rapid artrial fibrillation (with digitalis).
Ventricular arrhythmias
Left ventricular dysfunction.
Congestive heart failure.
Mild (LVEF = 40%).
Moderate to Severe (LVEF <40%).
Left-sided valvular heart disease.
Mild aortic stenosis.
Aortic insufficiency.
Mitral regurgitation.
Mitral stenosis
Hypertrophic cardiomyopathy
|
Betablockers (calcium antagonists) .
Betablockers (verapamil or dilitiazem).
Verapamil or Diltiazem.
Beta blockers.
Long-acting slow-release calcium antagonists.
Beta blockers (particularly if prior
myocardial infarction) or long-acting slow-release calcium
antagonists
Beta blockers or long-acting slow-release calcium antagonists.
Long-acting slow-release calcium antagonists.
Beta blockers or calcium antagonists
Calcium antagonists
Long-acting slow-release calcium antagonists
that do not decrease heart rate
Beta blockers.
Verapamil, diltiazem, or beta blockers.
Long-acting slow-release calcium antagonists
that do not slow AV conduction.
Verapamil, diltiazem, or beta blockers.
Beta blockers.
Beta blockers.
Amlodipine or felodipine (nitrates).
Beta blockers
Long-acting slow-release dihydropyridines
Long-acting slow-release dihydropyridines
Beta blockers.
Beta blockers.
nondihydropyridine calcium antagonist
Beta blockers Beta blockers
|
Beta blockers.
Beta blockers.
Beta blockers.
Beta blockers .
Beta blockers.
Beta blockers.Verapamil, diltiazem.
Verapamil, diltiazem.
Nitrates, dihydropyridine, calcium antagonists.
|